Ziarco Studie: Ziarco Pharma oral treatment against pruritus in atopic dermatitis
Laufzeit: 01.01.2015 - 31.12.2016
imported
Kurzfassung
A Randomized, Double-Blind, placebo controlled, parallel group study to determine the effects of 8 weeks treatment with oral ZPL-3893787 (30 mg OD x 56 days) on pruritus in adult subjects with Moderate to severe atopic dermatitis